Lilly International continues Lilly’s legacy to deliver innovative medicines that address unmet needs and have a profound impact on people’s lives around the world. More than 100 countries – 80 percent of the world’s population – and 6,000 employees make up Lilly International. Major regions and countries include Brazil, the United Kingdom, France, Spain, Italy, Germany, South Asia, the Middle East and the North Asia-Pacific.
What Makes Us Unique
With a well-balanced and diversified portfolio, Lilly International is driven by a clear strategic focus to make life better and deliver sustainable, profitable growth. Lilly International is experiencing underlying growth as Lilly brings much needed medications to people around the world. More than 50 potential launches by 2020 – including medicines in therapeutic areas such as oncology, diabetes and autoimmune diseases – will bring forth a steady share of market growth globally.
Lilly International is committed to making life better by creating meaningful impact with our partners around the world. This can be accomplished only by understanding what our customers truly value, and by providing extraordinary customer experiences through exceptional leadership and highly engaged employees.